Contemporary trends in survival in multiple sclerosis in the US: study design and rationale

被引：0
|
作者：
Cutter, G.
Reshef, S.
Golub, H.
Kaufman, D.
Brueckner, A.
Preblick, R.
Knappertz, V.
机构：
[1] Univ Alabama, Birmingham, AL USA
[2] Bayer HealthCare Pharmaceut Inc, Montville, NJ USA
[3] Care Safe LLC, Newton, MA USA
[4] Slone Epidemiol Ctr, Boston, MA USA
[5] Bayer Schering Pharma AG, Elbonfeld, DE USA
[6] Bayer HealthCare Pharmaceut Inc, Wayne, NJ USA
来源：
JOURNAL OF NEUROLOGY | 2010年 / 257卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P237
引用
收藏
页码：S76 / S76
页数：1
相关论文
共 50 条
  • [21] Trends in survival and cause of death in patients with multiple sclerosis in Northern Ireland
    Gray, OM
    Lim, LT
    Hawkins, SA
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (09): : 1317 - 1317
  • [22] Is there a rationale for therapeutic immunoadsorption in multiple sclerosis?
    Berger, T
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (08) : 467 - 468
  • [23] RATIONALE FOR IMMUNOTHERAPY IN MULTIPLE-SCLEROSIS
    WHITAKER, JN
    ANNALS OF NEUROLOGY, 1994, 36 : S103 - S107
  • [24] The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results
    Thiel, Sandra
    Ciplea, Andrea, I
    Gold, Ralf
    Hellwig, Kerstin
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [25] Survival in commercially insured multiple sclerosis patients and comparator subjects in the US
    Kaufman, D. W.
    Reshef, S.
    Golub, H. L.
    Peucker, M.
    Corwin, M. J.
    Goodin, D. S.
    Knappertz, V.
    Pleimes, D.
    Cutter, G.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2014, 3 (03) : 364 - 371
  • [26] Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study
    Nguyen, Ai-Lan
    Havrdova, Eva Kubala
    Horakova, Dana
    Izquierdo, Guillermo
    Kalincik, Tomas
    van der Walt, Anneke
    Terzi, Murat
    Alroughani, Raed
    Duquette, Pierre
    Girard, Marc
    Prat, Alexandre
    Boz, Cavit
    Sola, Patrizia
    Ferrara, Diana
    Lugaresi, Alessandra
    Lechner-Scott, Jeannette
    Barnett, Michael
    Grand'Maison, Francois
    Grammond, Pierre
    Ramo-Tello, Cristina
    Turkoglu, Recai
    McCombe, Pamela
    Pucci, Eugenio
    Trojano, Maria
    Granella, Franco
    Spitaleri, Daniele
    Van Pesch, Vincent
    Soysal, Aysun
    Oreja-Guevara, Celia
    Verheul, Freek
    Vucic, Steve
    Hodgkinson, Suzanne
    Slee, Mark
    Ampapa, Radek
    Prevost, Julie
    Sanchez Menoyo, Jose Luis
    Skibina, Olga
    Solaro, Claudio
    Olascoaga, Javier
    Shaw, Cameron
    Madsen, Klaus Gregaard
    Naidoo, Kerisha
    Hyde, Robert
    Butzkueven, Helmut
    Jokubaitis, Vilija
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 28 : 235 - 243
  • [27] Trends in survival and costs among US patients with multiple myeloma.
    Maiese, Eric
    Evans, Kristin
    Chu, Bong-Chul
    Irwin, Debra E.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08)
  • [28] Trends in survival and costs among US multiple myeloma patients.
    Maiese, Eric M.
    Evans, Kristin
    Chu, Bong-Chul
    Irwin, Debra E.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] Rationale and design for a study to evaluate the efficacy and safety of PEGylated interferon β-1a in patients with relapsing multiple sclerosis
    Calabresi, P. A.
    Arnold, D.
    Balcer, L.
    Boyko, A.
    Kieseier, B. C.
    Pelletier, J.
    Zhu, Y.
    Davar, G.
    JOURNAL OF NEUROLOGY, 2010, 257 : S148 - S149
  • [30] Contemporary Topics in Multiple Sclerosis
    Hersh, Carrie M.
    NEUROLOGIC CLINICS, 2024, 42 (01)
12345